BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Clinical Outcome
24 results:

  • 1. NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia.
    Shang CY; Bei LY; Wu JZ; Sheng HR; Yin H; Liang JH; Wang L; Li JY; Li Y; Xu W
    Ann Hematol; 2024 Mar; 103(3):833-841. PubMed ID: 37993586
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression.
    Wang F; Li Z; Zhou J; Wang G; Zhang W; Xu J; Liang A
    J Exp Clin Cancer Res; 2021 Aug; 40(1):259. PubMed ID: 34407842
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
    Bill M; Mrózek K; Giacopelli B; Kohlschmidt J; Nicolet D; Papaioannou D; Eisfeld AK; Kolitz JE; Powell BL; Carroll AJ; Stone RM; Garzon R; Byrd JC; Bloomfield CD; Oakes CC
    J Hematol Oncol; 2021 Jul; 14(1):107. PubMed ID: 34229733
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CARMA1 is required for notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
    Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
    J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
    Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
    Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biclonal lymphoproliferative disorders: another association with notch1-mutated chronic lymphocytic leukaemias.
    Fogarty H; Dowling A; O'Brien D; Langabeer S; Bacon CL; Flavin R; O'Dwyer M; Hennessy B; O'Leary H; Crotty G; Henderson R; Nolan J; Thornton P; Vandenberghe E; Quinn F
    Ir J Med Sci; 2021 Aug; 190(3):1087-1094. PubMed ID: 33068240
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].
    Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
    Zhonghua Nei Ke Za Zhi; 2020 Aug; 59(8):629-633. PubMed ID: 34865381
    [No Abstract]    [Full Text] [Related]  

  • 8. NOTCH-1 Gene Mutations Influence Survival in Acute Myeloid leukemia Patients.
    Aref S; Rizk R; El Agder M; Fakhry W; El Zafarany M; Sabry M
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):1987-1992. PubMed ID: 32711424
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MYC copy number and mRNA expression in chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chornobyl NPP accident.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2020 Mar; 42(1):60-65. PubMed ID: 32231192
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ultrasensitive Detection of notch1 c.7544_7545delCT Mutations in Chronic Lymphocytic leukemia by Droplet Digital PCR Reveals High Frequency of Subclonal Mutations and Predicts clinical outcome in Cases with Trisomy 12.
    Hoofd C; Huang SJ; Gusscott S; Lam S; Wong R; Johnston A; Ben-Neriah S; Steidl C; Scott DW; Bruyere H; Gillan TL; Toze CL; Gerrie AS; Weng AP
    J Mol Diagn; 2020 Apr; 22(4):571-578. PubMed ID: 32036086
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Significance of notch1 mutations détections in T-acute lymphoblastic leukemia patients.
    Aref S; El Agdar M; Salama O; Zeid TA; Sabry M
    Cancer Biomark; 2020; 27(2):157-162. PubMed ID: 31796666
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.
    Ronchetti D; Manzoni M; Agnelli L; Vinci C; Fabris S; Cutrona G; Matis S; Colombo M; Galletti S; Taiana E; Recchia AG; Bossio S; Gentile M; Musolino C; Di Raimondo F; Grilli A; Bicciato S; Cortelezzi A; Tassone P; Morabito F; Ferrarini M; Neri A
    Blood Cancer J; 2016 Sep; 6(9):e468. PubMed ID: 27611921
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Mutation of IL-7R in Adult Patients with T-cell Acute Lymphoblastic leukemia and Its clinical Significance].
    Xiao LC; Li M; Ge Z; Gu Y; Zhou XL; Guo X; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1014-8. PubMed ID: 27531766
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
    Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
    Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
    D'Avola A; Drennan S; Tracy I; Henderson I; Chiecchio L; Larrayoz M; Rose-Zerilli M; Strefford J; Plass C; Johnson PW; Steele AJ; Packham G; Stevenson FK; Oakes CC; Forconi F
    Blood; 2016 Aug; 128(6):816-26. PubMed ID: 27301861
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
    Del Principe MI; Dal Bo M; Bittolo T; Buccisano F; Rossi FM; Zucchetto A; Rossi D; Bomben R; Maurillo L; Cefalo M; De Santis G; Venditti A; Gaidano G; Amadori S; de Fabritiis P; Gattei V; Del Poeta G
    Haematologica; 2016 Jan; 101(1):77-85. PubMed ID: 26565002
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.
    Sciumè M; Vincenti D; Reda G; Orofino N; Cassin R; Giannarelli D; Gaidano G; Rossi D; Cortelezzi A
    Am J Hematol; 2015 Nov; 90(11):970-4. PubMed ID: 26201283
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.
    Yang L; Zhang S; George SK; Teng R; You X; Xu M; Liu H; Sun X; Amin HM; Shi W
    Oncotarget; 2015 Jun; 6(17):14953-69. PubMed ID: 25879451
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.
    Shahjahani M; Mohammadiasl J; Noroozi F; Seghatoleslami M; Shahrabi S; Saba F; Saki N
    Cell Oncol (Dordr); 2015 Apr; 38(2):93-109. PubMed ID: 25563586
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. notch1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
    Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.